• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH LACTATE DEHYDROGENASE (LDH); NAD REDUCTION/NADH OXIDATION, LACTATE DEHYDROGENASE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH LACTATE DEHYDROGENASE (LDH); NAD REDUCTION/NADH OXIDATION, LACTATE DEHYDROGENASE Back to Search Results
Model Number 2P56-22
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 01/13/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(6).There was no additional patient information provided by the customer due to privacy issues.A review of tickets determined that there is not an increase in complaint activity for ldh reagent lot 02747un20.Trending review determined no trends for falsely elevated results for the product.Return testing was not completed as returns were not available.File sample testing was not performed as the original sample generated correct results upon retesting.Quality control has been in range at the time of the incident.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation, no systemic issue or deficiency of the lactate dehydrogenase (ldh) reagent, lot number 02747un20, was identified.
 
Event or Problem Description
The customer reported falsely elevated lactate dehydrogenase (ldh) results on one patient generated on the architect analyzer.The results provided were: on (b)(6) 2021 (b)(6) initial = 1563.0u/l (normal range 125-220u/l) / retest = 147 and 148u/l.There was no reported impact to patient management.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LACTATE DEHYDROGENASE (LDH)
Common Device Name
NAD REDUCTION/NADH OXIDATION, LACTATE DEHYDROGENASE
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key11215775
Report Number3002809144-2021-00047
Device Sequence Number14367086
Product Code CFJ
UDI-Device Identifier00380740161460
UDI-Public00380740161460
Combination Product (Y/N)N
PMA/510(K) Number
EXEMPT
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,health professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 01/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/16/2021
Device Model Number2P56-22
Device Catalogue Number02P56-22
Device Lot Number02747UN20
Was Device Available for Evaluation? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/13/2021
Initial Report FDA Received Date01/22/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-